Since there is frequent PD-L1 expression in tumors with a high infiltrate of CD8-positive TILs (constituting an “adaptive immune resistance” tumor microenvironment), NSND should in theory be interesting candidates for treatment with ICIs. Here, CD8A is linked to neoplasm.